Search for: "White v. Pfizer Inc."
Results 41 - 57
of 57
Sorted by Relevance
|
Sort by Date
3 Jun 2010, 1:37 pm
Pfizer, Inc., 2007 WL 969431 (N.Y. [read post]
15 Jul 2010, 2:39 pm
White v. [read post]
7 Feb 2008, 10:46 am
The leading case is Kemp v. [read post]
14 Jul 2012, 7:08 am
Philip Morris USA, Inc., 449 F. [read post]
23 Jul 2012, 7:33 am
In In re Pfizer Inc. [read post]
27 Jun 2008, 10:04 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Court reconsidering baseless ‘making available’ theory in file-sharing case Capitol Records v Jammie Thomas; amicus briefs from, MPAA, PFF: (Electronic Frontier Foundation), (Electronic Fontier Foundation), (Techdirt), (Ars Technica), (Patry Copyright Blog), (Patry Copyright Blog) ICANN approves rules allowing brands to be… [read post]
28 Apr 2011, 3:18 pm
Brown v. [read post]
16 Aug 2009, 9:51 pm
In reliance of Black & Decker, Inc. v Robert Bosch Tool Corp (2008) Microsoft argued that the objective prong of the willfulness analysis is satisfied only if a defendant fails to present valid defences during the proceedings. [read post]
28 Mar 2008, 6:00 am
: (Afro-IP),If education and pricing policy fail, says Adobe in Nigeria, we can still sue: (Afro-IP),South African arm of Chrysler objects to advertisement by Indian vehicle maker Mahindra and Mahindra that uses the term "jeep": (Afro-IP), (Spicy IP),Kenya’s call for anti-counterfeit legislation… amongst other changes: (Afro-IP),Kenya: Shared computer use raises privacy, confidentiality issues: (Afro-IP)AustraliaChanges to grace period for trade mark renewal:… [read post]
2 Sep 2022, 5:01 am
All this suggests that providing pseudonymity to members of particular religious groups might violate the principle of the Texas Monthly v. [read post]
9 Mar 2010, 12:20 am
Though the justices almost never reveal their reasons for recusal, this one is almost certainly based on Roberts' stock ownership in Pfizer, which also became an issue in last year's landmark pre-emption case Wyeth v. [read post]
15 Feb 2008, 9:00 am
: (Spicy IP),USD 20 billion going off-patent: (Patent Circle),Canadian Prices Review Board asserts jurisdiction over products sold in US, but imported into Canada under Special Access Program: (Gowlings),Canadian Court of Appeal affirms decision allowing patent-owner to be joined to proceedings: Cobalt v Pfizer and Pharmascience v Pfizer: (Gowlings),PharmaStem appeals stem cell patent: asks for greater deference to patent… [read post]
1 Feb 2008, 12:00 am
: Industries Ltd v Dynamic Supply Pty Ltd: (IP Down Under)BrazilIFPI raids hundreds of internet cafes: 600 cops, one arrest: (Ars Technica)CanadaInterlocutory injunctions in trade mark cases: a difficult test to meet: CMAC Mortgages v Canadian Mortgage Expert Centre and CanadaHyundai Autov Cross Canada Auto Body Supply: (Canadian Trademark Blog), (coverage of Hyundia - IPblog), Privacy Coalition warns on copyright reform: (Michael Geist),Wikinomics on… [read post]
7 Mar 2008, 2:00 am
: (IPBiz), US: Proposals for the approval of generic biologics under consideration: (Pharmacapsules@Gowlings), US: A paradigm shift in obviousness for pharma, biotech: (IP Law360), US: USPTO’s Bruce Kisliuk addresses ACI Pharma/biotech patent claim drafting and prosecution conference: (Patent Docs), US: New bill to provide biotech companies Sarbanes-Oxley relief: (California Biotech Law Blog), US: Biotech and pharma companies spent millions on lobbying in 2007: (Patent… [read post]
11 Apr 2008, 9:00 am
No problem…: Lundbeck A/S v Generics UK Ltd & Ors: (IPKat), Exelon (Rivastigmine Tartrate) – Dr Reddy’s and Novartis settle Exelon patent dispute: (Therapeutics Daily), GeneMaker – Codon Devices, Blue Heron Biotechnology settle patent suit over gene synthesis platform: (Patent Docs), Glucophage (Metformin) – Depomed settles patent litigation against IVAX: (SmartBrief), (IP Law360), (GenericsWeb), Lexapro… [read post]
22 Mar 2008, 2:00 am
: (IPBiz),US: Two remaining challenged WARF embryonic stem cell patents upheld in ex parte reexamination: (Holman's Biotech IP Blog), Pharma & Biotech - ProductsAricept (Donepezil) – USV wins appeal against USPTO decision: (Spicy IP),Celerex (Celecoxib) – CAFC decision in Celebrex patents dispute between Pfizer and Teva will cut patent term by one and a half years: (Patent Baristas), Inersan – Ranbaxy in-licenses Inersan to CD Pharma to market in… [read post]
3 Jan 2023, 1:47 pm
The directors’ and officers’ liability environment is always changing, but 2022 was a particularly eventful year, with important consequences for the D&O insurance marketplace. [read post]
